Acupuncture Needles Market Size & Share 2026-2035

Acupuncture Needles Market Size

The global acupuncture needles market was valued at USD 306.6 million in 2025 and is projected to grow from USD 328.8 million in 2026 to USD 647.8 million by 2035, expanding at a CAGR of 7.8%, according to the latest report published by Global Market Insights Inc.

The market growth is driven surge in prevalence of chronic diseases, increasing number of people suffering from muscular pain and growing adoption of acupuncture in rehabilitation of COPD patients. The market increased from USD 267.4 million in 2023 to USD 286.1 million in 2024. The surge in chronic diseases worldwide is a major driver of the acupuncture needles market, as the growing burden of long-term conditions increases the demand for effective, low‑risk, and complementary therapies. For instance, the global diabetic population rose sharply from 200 million in 1990 to 830 million in 2022, with prevalence accelerating most rapidly in low‑ and middle‑income countries, highlighting a broader trend of metabolic and lifestyle‑related disorders requiring continuous symptom management.
 

As chronic conditions such as diabetes, obesity, and cardiovascular disease often lead to complications like neuropathy, systemic pain, sleep disruption, and emotional stress, patients increasingly turn to acupuncture for its proven ability to alleviate pain and regulate physiological functions. the rising prevalence of chronic diseases, combined with obesity and alcoholism-related complications, is directly fueling demand for acupuncture treatments. Similarly, the global rise in chronic pain spanning back pain, osteoarthritis, and migraines has intensified the need for non‑pharmacological interventions, pushing patients and practitioners toward acupuncture as a safe alternative to drug‑based therapies.
 

Additionally, concerns surrounding medication side effects and long‑term dependence further reinforce acupuncture’s appeal, especially in healthcare environments prioritizing holistic and preventive care. As a result, the increasing chronic disease burden worldwide drives the sustained demand for high‑quality acupuncture needles essential for effective treatment delivery.
 

Rising awareness regarding alternative therapies is becoming a key driver for the acupuncture needles market, as consumers increasingly prioritize holistic, drug‑free, and non‑invasive treatment options for managing pain, stress, and chronic conditions. Growing familiarity with traditional medical practices and mind‑body wellness has encouraged more individuals to explore acupuncture as a credible and effective therapeutic approach. This shift is reinforced by a broader movement toward natural health solutions and integrative care, where acupuncture is gaining traction for its role in improving overall well‑being and reducing reliance on conventional pain medications.
 

As public interest in preventive healthcare and wellness‑focused lifestyles continues to expand across global markets, the demand for acupuncture services rises , thereby driving sustained growth in the consumption of acupuncture needles by clinics, wellness centers, and trained practitioners.

Acupuncture needles are thin, sterile, filiform instruments designed for insertion at specific points on the body to stimulate physiological responses. They are typically made to precise medical standards to ensure safety, minimal discomfort, and controlled penetration. Used within traditional Chinese medicine and modern therapeutic practices, these needles help modulate pain, support healing processes, and restore functional balance in the body.

Acupuncture Needles Market Trends

• Acupuncture has increasingly gained recognition as a supportive therapeutic modality in chronic disease management, particularly within respiratory care. As a traditional Chinese medical practice, acupuncture involves stimulating specific points in the body using fine needles to modulate physiological functions, reduce pain, and enhance wellness. In modern clinical settings, acupuncture integrated into multidisciplinary treatment frameworks for chronic disorders, including musculoskeletal pain, inflammation, and functional impairments. Its expanded clinical acceptance strengthens the case for acupuncture needles as an essential consumable in growing therapeutic categories.
   
• Chronic Obstructive Pulmonary Disease (COPD) presents sustained treatment challenges, including breathlessness, reduced lung function, and compromised exercise tolerance, often requiring multimodal rehabilitation strategies. As COPD progresses, patients frequently struggle with persistent muscular fatigue, respiratory distress, and sleep difficulties areas where acupuncture has demonstrated complementary benefits. Acupuncture is used to stimulate respiratory muscles, reduce anxiety associated with dyspnea, and potentially improve airflow and oxygen utilization. Clinical programs focused on COPD rehabilitation increasingly integrate acupuncture to address chronic pain, muscle stiffness, and psychosomatic symptoms, supporting an improved quality of life and functional recovery.
   
• The integration of acupuncture into COPD rehabilitation directly contributes to the rising demand for acupuncture needles in the global market. As healthcare providers adopt non-pharmacological therapies to reduce dependence on drugs especially in elderly patients acupuncture becomes an appealing alternative. The high prevalence of chronic diseases and the need for ongoing rehabilitative therapies amplify needle consumption rates.
   
• As a result, the increasing use of acupuncture as part of COPD rehabilitation strengthens the market by expanding clinical applications, increasing treatment frequency, and enhancing adoption in both hospitals and specialty clinics.
   

Acupuncture Needles Market Analysis

Based on product, the acupuncture needles market is bifurcated into disposable and reusable. The disposable segment dominated the market with the largest revenue of USD 175.4 million in 2025.
 

• Disposable acupuncture needles are single‑use, sterile medical needles designed to be used once and safely discarded. They are typically made from stainless steel with silicone coatings and come individually packaged to ensure maximum hygiene. Their design minimizes the risk of infection, cross‑contamination, and procedural discomfort during acupuncture treatments.
   
• The widespread adoption of disposable needles significantly boosts market demand due to their alignment with strict global safety protocols and infection‑control standards. As healthcare practitioners increasingly prioritize patient safety and regulatory compliance, the shift toward single‑use needles accelerates procurement volumes across clinics, hospitals, and wellness centers. Growing patient awareness and preference for sterile, hygienic treatment methods also reinforce the dominance of disposable needles, strengthening overall market expansion.
   
• For instance, SEIRIN produces high‑quality disposable acupuncture needles, such as the SEIRIN J‑Type, which is widely used for its precision, patient comfort, and consistent safety standards.
   
• As a result, disposable acupuncture needles play a critical role and is widely adopted due to their safety, regulatory compliance, and patient confidence.
   

Based on material, the acupuncture needles market is segmented into stainless steel, gold, silver, and others. The stainless steel segment dominated the market with the largest revenue of USD 136.2 million in 2025.
 

• Stainless steel dominates the market primarily due to its strength, corrosion resistance, biocompatibility, and cost‑effectiveness, making it the preferred material for high‑precision therapeutic applications.
   
• Stainless steel needles maintain structural integrity during insertion, offer smooth penetration especially when silicone‑coated and ensure consistent performance across treatments.
   
• Additionally, Their durability and sterilization compatibility make them suitable for mass production, allowing manufacturers to maintain quality while keeping prices competitive. As a result, stainless steel provides the ideal balance of safety, reliability, and affordability for both practitioners and patients.
   
• For instance, 3B Scientific GmbH offers stainless‑steel acupuncture needles like the Millennia 5 Needle Pack, designed for smooth insertion and high tensile strength demonstrating how stainless steel’s performance qualities continue to drive its dominance in the market.
   

Based on applications, the acupuncture needles market is segmented into muscular pain, migraine, sports injuries, arthritis and other applications. The muscular pain segment held the largest revenue of USD 110.9 million in 2025.
 

• Muscular pain refers to discomfort, soreness, or inflammation that affects the muscles, often resulting from tension, overuse, strain, poor posture, or underlying musculoskeletal disorders. It can range from mild stiffness to severe, movement‑limiting pain and is commonly associated with conditions such as low back pain, neck pain, shoulder tension, and widespread musculoskeletal fatigue.
   
• Muscular pain is one of the most common reasons individuals seek acupuncture treatment, making it a dominant application segment in the acupuncture needles market. As the prevalence of musculoskeletal disorders continues to rise, healthcare providers, wellness centers, and sports rehabilitation facilities increasingly adopt acupuncture as a reliable, non‑pharmacological intervention for pain relief and functional recovery. The demand for safe, minimally invasive treatment options, especially those that reduce reliance on medication, further accelerates the use of acupuncture needles.
   
• For instance, According to the World Health Organization (WHO), approximately 1.71 billion people worldwide live with musculoskeletal conditions, making them the leading contributor to disability across the globe. Low back pain alone is the single leading cause of disability in 160 countries, underscoring the massive global burden of muscular and musculoskeletal disorders. This widespread incidence strongly supports the need for effective pain‑management therapies such as acupuncture and elevates the demand for acupuncture needles in clinical practice.
   

Based on end use, the acupuncture needles market is segmented into hospitals, clinics, and other end users. The hospitals segment dominated the market with the largest revenue of USD 136 million in 2025 and is expected to grow at a lucrative CAGR over the forecast period.
 

• Hospitals dominate the market because they serve as the primary centers for treating complex, chronic, and acute medical conditions many of which increasingly incorporate acupuncture as part of integrated care. Hospitals commonly manage patients suffering from chronic pain, orthopedic issues, postoperative recovery needs, neurological disorders, and musculoskeletal conditions, all of which benefit from acupuncture as an adjunct therapy. Their structured clinical environments, specialist availability, and access to interdisciplinary treatment pathways make hospitals the first point of adoption when acupuncture becomes recognized as an evidence‑backed clinical intervention.
   
• Hospitals not only have the highest patient inflow but also adopt acupuncture at scale due to integration of traditional and complementary medicine into mainstream care protocols. As acupuncture gains recognition for reducing pain, improving functional recovery, and supporting rehabilitation, hospitals increasingly embed it within physiotherapy, pain‑management, oncology support, and postoperative care programs. This widespread clinical adoption directly increases the procurement of acupuncture needles.
   
• As a result, hospitals dominate the acupuncture needles market because they treat the wide range of conditions that benefit from acupuncture, integrate it into clinical pathways, and purchase needles in high volumes to support regulated, evidence‑based therapeutic practice. This combination of clinical need, institutional adoption, and large‑scale procurement ensures hospitals remain the leading end‑use segment in the market.
   

North America Acupuncture Needles Market

The North America region accounted for 25% of the market share in 2025, driven by the increasing prevalence of chronic diseases.
 

• The U.S. acupuncture needles industry was valued at USD 58.3 million and USD 66.5 million in 2022 and 2023, respectively. The market size reached USD 71.1 million in 2025, growing from USD 66.5 million in 2024.
   
• The growing prevalence of muscular pain represents a major driver for the acupuncture needles market, as more individuals seek effective, non‑pharmacological pain‑management solutions. Muscular pain, often stemming from chronic conditions, stress, poor posture, or repetitive strain, significantly disrupts daily function and quality of life, prompting patients to look for therapeutic alternatives that offer relief without reliance on medication.
   
• For instance, according to NIH, during 2021, an estimated 20.9% of U.S. adults (51.6 million people) experienced chronic pain, while 6.9% (17.1 million) suffered from high‑impact chronic pain, which restricts daily activities and often includes persistent muscular discomfort.
   
• This widespread burden has accelerated adoption of acupuncture needles as a safe, minimally invasive, and cost‑effective therapy. As more patients and clinicians adopt acupuncture for managing chronic musculoskeletal pain, the demand for high‑quality acupuncture needles continues to grow.
   

Europe Acupuncture Needles Market

Europe acupuncture needles industry accounted for USD 68 million in 2025 and is anticipated to show lucrative growth over the forecast period.
 

• The rising prevalence of chronic diseases across Europe is a major driver accelerating the growth of the market. Chronic conditions such as diabetes, cardiovascular disease, arthritis, and chronic musculoskeletal pain continue to expand due to aging populations, sedentary lifestyles, and increasing obesity rates. As these long‑term illnesses frequently result in persistent pain, neuropathy, inflammation, and reduced mobility, healthcare providers and patients are increasingly seeking complementary therapeutic solutions that offer relief without relying solely on pharmaceuticals.
   
• Acupuncture recognized for its ability to alleviate pain, reduce inflammation, and improve functional outcomes has therefore become an important adjunct within Europe’s evolving integrative healthcare landscape.
   
• According to the International Diabetes Federation, the estimated diabetes prevalence in the Europe (EUR) Region is 9.8%, with 66 million people currently living with diabetes, and this figure is projected to increase by 10% by 2050. Given diabetes’ strong association with chronic pain, neuropathy, and mobility limitations, this growing patient population substantially increases the demand for non‑pharmacological interventions like acupuncture.
   
• As healthcare systems prioritize long‑term, sustainable, and patient‑centric pain‑management approaches, the market is expected to continue experiencing strong and steady growth.
   

Germany's acupuncture needles market is projected to experience steady growth between 2026 and 2035.
 

• Germany’s acupuncture market is significantly driven by the rising burden of chronic musculoskeletal disorders particularly back and neck pain which continue to affect a majority of the population. Musculoskeletal pain is one of the most common long‑term health issues in the country, reducing daily functioning and quality of life while increasing the demand for alternative and complementary treatment options.
   
• For instance, according to NIH, 61.3% of people in Germany reported back pain at least once in the past twelve months, and 45.7% reported neck pain during the same period. Moreover, women reported back pain more frequently (66%) compared to men (56.4%), underscoring a substantial and diverse patient population seeking relief. Such widespread discomfort drives individuals toward acupuncture as a safe, minimally invasive, and clinically beneficial solution—reinforcing steady demand for acupuncture needles.
   
• As the prevalence of back and neck pain continues to rise and patients increasingly turn toward holistic, non‑drug therapies, acupuncture will remain a central component of pain‑management strategies, stimulating market growth.
   

Asia Pacific Acupuncture Needles Market

The Asia Pacific region is projected to show a lucrative growth of about 8.5% during the forecast period.
 

• The Asia‑Pacific region is witnessing a rising integration of acupuncture into rehabilitation programs for chronic obstructive pulmonary disease (COPD. COPD remains a significant public health challenge across Asia‑Pacific, where exposure to air pollution, biomass fuels, and smoking rates contribute to a high and growing disease burden.
   
• As healthcare systems prioritize non‑pharmacological, supportive therapies that improve breathing function, reduce dyspnea, and enhance overall quality of life, acupuncture is increasingly recognized for its value in respiratory rehabilitation.
• For instance, COPD prevalence in the Asia‑Pacific region is estimated at 14.5% in Australia, 4.4% to 16.7% in China, and 5.6% in Indonesia, according to NIH.
   
• These high population‑level rates translate into millions of patients requiring ongoing management, making acupuncture a valuable adjunct therapy within rehabilitation pathways.
   

Japan acupuncture needles market is poised to witness lucrative growth between 2026 and 2035.
 

• The Japan acupuncture market is strongly driven by the growing number of individuals experiencing muscular pain, often linked to modern lifestyle pressures, aging demographics, and a high participation rate in sports and physical activities. Muscular pain in Japan commonly arises from conditions such as chronic tension, arthritis, postural strain, and sports‑related injuries.
   
• Sports injuries represent a particularly significant contributor to the rising burden of muscular pain. According to NIH findings, the overall 1‑year sports injury prevalence among Japanese collegiate athletes was 50.01% (5,500 injured out of 10,998 athletes). Injury prevalence in males (52.02%) was notably higher than in females (46.65%), underscoring the widespread nature of musculoskeletal injuries across demographics. These statistics reflect a strong and ongoing need for effective sports medicine interventions capable of supporting fast recovery, reducing inflammation, and preventing long‑term complications.
   
• As a result, the rising incidence of muscular pain, driven by sports injuries, arthritis, and lifestyle factors, is substantially boosting demand for acupuncture needles in Japan.
   

Latin America Acupuncture Needles Market

Brazil is experiencing significant growth in the acupuncture needles industry.
 

• Growing public awareness and acceptance of alternative and complementary therapies is becoming a driver for the Brazil market. Across the region, patients are increasingly seeking holistic, culturally aligned, and non‑drug‑based treatments to manage conditions such as chronic pain, stress, muscular disorders, and lifestyle‑related ailments.
   
• As more Brazilians seek safer, less invasive approaches to health management, acupuncture has gained substantial traction as a credible and effective therapeutic option.
   
• This increasing awareness and demand directly increase the consumption of acupuncture needles across clinics, wellness centers, and rehabilitation facilities in Brazil stimulating the market growth.
   

Middle East and Africa Acupuncture Needles Market

• The rising burden of chronic diseases in Saudi Arabia is becoming a key force driving the growth of the acupuncture needles industry. As the country experiences rapid lifestyle transitions marked by reduced physical activity, increased rates of obesity, diabetes, hypertension, and musculoskeletal disorders the demand for long‑term, sustainable, and non‑pharmacological treatment options continues to rise.
   
• Saudi Arabia’s healthcare system is also increasingly incorporating complementary medicine into clinical practice. As chronic disease prevalence grows, physicians, rehabilitation centers, and wellness clinics are turning to acupuncture as an adjunct treatment for complications such as diabetic neuropathy, chronic back pain, arthritis, and stress‑related conditions.
  
   
• As more patients and providers embrace acupuncture to manage chronic symptoms safely and effectively, the market continues to expand steadily across the region.
   

Acupuncture Needles Market Share

• The leading companies in the acupuncture needles industry include SEIRIN Corporation, Suzhou Zhongjing Life & Science Technology, Boen Healthcare, 3B Scientific GmbH, and Suzhou Hualun Medical, collectively accounting for a 80% market share of the global market.
   
• Leading companies in the acupuncture needles market are accelerating innovation to enhance treatment precision, patient comfort, and practitioner efficiency globally. They are developing ultra‑fine, silicone‑coated needles, advanced single‑use sterile formats, and ergonomic handle designs to reduce insertion discomfort and improve procedural accuracy.
   
• Companies are forming alliances with traditional physiotherapy centers, wellness clinics, and hospital networks to broaden access to certified, high‑quality acupuncture tools especially in emerging markets across Asia-Pacific, Latin America, and the Middle East.
   
• As the demand for acupuncture rises in chronic pain management, sports rehabilitation, and wellness therapies, adherence to stricter regulatory frameworks and certification requirements is becoming essential. These advancements collectively support safer treatments, consistent product quality, and greater adoption across healthcare settings.
   
• Many emerging manufacturers emphasize cost‑efficient production and volume supply, appealing to price‑sensitive practitioners and training centers. These players often focus on localized customization such as producing specialized intradermal needles, ear needles, or cosmetic acupuncture tools to serve specific therapeutic segments. Their market expansion relies more on third‑party distributors, online sales channels, and localized partnerships rather than direct global operations, enabling them to reach new markets with minimal investment.
   

Acupuncture Needles Market Companies

Few of the prominent players operating in the acupuncture needles industry include:

• 3B SCIENTIFIC GMBH
• AcuMedic Ltd
• asia-med GmbH
• SEIRIN
• Dana Medical Co
• Boen Healthcare Co Ltd
• Suzhou Hualun
• WUXI JIAJIAN MEDICAL DEVICES CO LTD
• Suzhou Zhongjing Life & Science Technology Co., Ltd
• Shinylink (Shanghai) Industrial Inc
• MeyerDC,
• Phoenix Medical
   
• SEIRIN Corporation

SEIRIN Corporation is well‑known for producing high‑precision acupuncture needles supported by strict quality standards and consistent manufacturing practices. The company applies advanced production methods and ongoing research efforts to enhance needle performance, patient comfort, and safety. SEIRIN operates across several regions, including Japan, Germany, China, and the United States, allowing wide access to its product range. Its steady focus on product refinement and dependable manufacturing makes it an important contributor within the acupuncture needles market.
 

• Suzhou Zhongjing Life & Science Technology

Suzhou Zhongjing Life & Science Technology has decades of experience in producing acupuncture supplies supported by standardized processes and established quality frameworks. The company operates with internationally recognized certifications, reflecting adherence to regulatory and operational requirements. Its long-term commitment to process stability and technical consistency enables it to maintain a strong presence in various regions.
 

• Boen HealthcareCo., Ltd

Boen Healthcare Co., Ltd operates as a comprehensive manufacturer with structured supply chain capabilities and the ability to support both standard and customized production needs. The company’s certification framework and emphasis on operational efficiency allow it to serve a wide customer base. Its ongoing investment in improving manufacturing practices and service support contributes to its standing in the market.
 

Acupuncture Needles Industry News:

• In October 2025, TCMzone, LLC announced that it had partnered with Suzhou Medical Appliance Factory, the manufacturer of the Hua Tuo™ brand acupuncture needles. The collaboration enabled TCMzone to distribute these high‑quality needles produced by one of China’s oldest and largest acupuncture‑instrument manufacturers—to licensed healthcare practitioners across the United States. The partnership aimed to expand access to professionally vetted acupuncture supplies and strengthen the availability of traditional Chinese medical tools within U.S. clinical practice.
   

The acupuncture needles market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million and from 2022 – 2035 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Disposable
• Reusable

Market, By Materials

• Stainless steel
• Gold
• Silver
• Other materials

Market, By Application

• Muscular pain
• Migraine
• Sports injuries
• Arthritis
• Other applications

Market, By End use

• Hospitals
• Clinics
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE